NEW YORK (Reuters Health) - A modernized version of the world's first bicycle could help some people with emphysema get around more easily, a small pilot study suggests.
The study, published in the journal Chest, looked at the effects of a walking aid dubbed the "modern draisine." The draisine, which was invented in 1817, was a pedal-free prototype for today's bicycle.
Some manufacturers are now making a draisine-like device as a walking aid for people with mobility problems: They sit on the seat and hold the handlebars while using their feet on the ground to propel themselves along.
There are already walking aids for people with chronic obstructive pulmonary disease (COPD) -- a group of lung diseases that includes emphysema and chronic bronchitis.
One of those is the "rollator" -- a four-wheeled frame with handles that people push in front of them as they walk. The frame also has a basket so COPD patients can carry their portable oxygen tanks.
But people can be self-conscious about using the rollator. One small study found that 48 percent of COPD patients using a rollator said they felt "embarrassed" while using the device.
So for the new study, researchers tested the draisine device against a rollator among 21 COPD patients who had difficulty getting around on their own.
They found that the patients did a bit better on an indoor walking test when they used the bike-like device. They covered an average of 466 meters (1,529 feet) in 6 minutes, compared with 383 meters (1,257 feet) while using the rollator.
The study participants also seemed less self-conscious about the draisine: 10 percent said they felt embarrassed using it, while 19 percent said the same about the rollator.
Because the draisine has a seat, it may take some of the "load" off COPD patients' legs, according to lead researcher Anouk W. Vaes of CIRO, a Horn, Netherlands-based center that specializes in treating chronic organ failure.
In an email, Vaes said the draisine also seems to give users a more "fixed center of gravity," and possibly a more effective walking pattern, than the rollator.
But whether the draisine will take over as COPD patients' walking aid of choice remains to be seen.
Even though patients in this study were less likely to say the bike-like device embarrassed them, they were actually more willing to use the rollator in their daily lives. Of the 21 patients, 16 said they would use the rollator day-to-day, but only eight said they would use the draisine.
One problem, Vaes said, was that some people felt less balanced and secure on the two-wheeled draisine versus the four-wheeled rollator.
"This may improve after patients have used it for a longer period," Vaes noted, "but that remains currently unknown."
Right now, the draisine is not widely used among COPD patients, according to Vaes. But there are several models of the walking aid available in the Netherlands.
A major downside of the device is its cost -- which is roughly five times that of a typical rollator, according to the researchers.
The draisine used in this study retails for 520 euros, or about $680.
Vaes said that larger studies are needed to confirm the better walk performance seen with the draisine. She and her colleagues are also testing the draisine against the rollator in outdoor settings, where people would actually use them in real life.
None of the researchers reports any financial interests in the work.
SOURCE: http://bit.ly/vQrIO8 Chest, online November 23, 2011.
Our 2024 Coverage Needs You
It's Another Trump-Biden Showdown — And We Need Your Help
The Future Of Democracy Is At Stake
Our 2024 Coverage Needs You
Your Loyalty Means The World To Us
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
The 2024 election is heating up, and women's rights, health care, voting rights, and the very future of democracy are all at stake. Donald Trump will face Joe Biden in the most consequential vote of our time. And HuffPost will be there, covering every twist and turn. America's future hangs in the balance. Would you consider contributing to support our journalism and keep it free for all during this critical season?
HuffPost believes news should be accessible to everyone, regardless of their ability to pay for it. We rely on readers like you to help fund our work. Any contribution you can make — even as little as $2 — goes directly toward supporting the impactful journalism that we will continue to produce this year. Thank you for being part of our story.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
It's official: Donald Trump will face Joe Biden this fall in the presidential election. As we face the most consequential presidential election of our time, HuffPost is committed to bringing you up-to-date, accurate news about the 2024 race. While other outlets have retreated behind paywalls, you can trust our news will stay free.
But we can't do it without your help. Reader funding is one of the key ways we support our newsroom. Would you consider making a donation to help fund our news during this critical time? Your contributions are vital to supporting a free press.
Contribute as little as $2 to keep our journalism free and accessible to all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. Would you consider becoming a regular HuffPost contributor?
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. If circumstances have changed since you last contributed, we hope you'll consider contributing to HuffPost once more.
Support HuffPostAlready contributed? Log in to hide these messages.